Aprio Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
ATO
CGH
Aprio Wealth Management's GILD Position: Q2 2026 in Review
Aprio Wealth Management reduced its Gilead Sciences (GILD) stake by 2.6% in Q2 2026, selling an estimated $55.2K and leaving 15,500 shares worth $1.96M. The position accounts for 0.1% of the portfolio, ranked #148.
Aprio Wealth Management first reported a position in GILD in Q3 2023 and has held it in 10 quarters since. The position peaked at $2.22M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Aprio Wealth Management held 15,500 shares of Gilead Sciences worth $1.96M as of Q2 2026.
- Aprio Wealth Management sold 419 Gilead Sciences shares in Q2 2026, an estimated $55.2K.
- Gilead Sciences made up 0.1% of Aprio Wealth Management's portfolio in Q2 2026, its #148 holding.
- Aprio Wealth Management first reported a position in Gilead Sciences in Q3 2023 and has held it in 10 quarters since.
- Aprio Wealth Management's Gilead Sciences position peaked at $2.22M in Q1 2026.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Aprio Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.